Silverfin false false 30/04/2024 24/04/2023 30/04/2024 Dr Munisha Balain 24/04/2023 Dr Clare Hollingsworth 24/04/2023 Dr William Peter Verling 24/04/2023 20 January 2025 The principal activity of the Company during the financial year was other education. 14823406 2024-04-30 14823406 bus:Director1 2024-04-30 14823406 bus:Director2 2024-04-30 14823406 bus:Director3 2024-04-30 14823406 2023-04-23 14823406 core:CurrentFinancialInstruments 2024-04-30 14823406 core:CurrentFinancialInstruments 2023-04-23 14823406 core:ShareCapital 2024-04-30 14823406 core:ShareCapital 2023-04-23 14823406 core:RetainedEarningsAccumulatedLosses 2024-04-30 14823406 core:RetainedEarningsAccumulatedLosses 2023-04-23 14823406 bus:OrdinaryShareClass1 2024-04-30 14823406 2023-04-24 2024-04-30 14823406 bus:FilletedAccounts 2023-04-24 2024-04-30 14823406 bus:SmallEntities 2023-04-24 2024-04-30 14823406 bus:AuditExemptWithAccountantsReport 2023-04-24 2024-04-30 14823406 bus:PrivateLimitedCompanyLtd 2023-04-24 2024-04-30 14823406 bus:Director1 2023-04-24 2024-04-30 14823406 bus:Director2 2023-04-24 2024-04-30 14823406 bus:Director3 2023-04-24 2024-04-30 14823406 2022-05-01 2023-04-23 14823406 bus:OrdinaryShareClass1 2023-04-24 2024-04-30 14823406 bus:OrdinaryShareClass1 2022-05-01 2023-04-23 iso4217:GBP xbrli:pure xbrli:shares

Company No: 14823406 (England and Wales)

PARENTMED LIMITED

Unaudited Financial Statements
For the financial period from 24 April 2023 to 30 April 2024
Pages for filing with the registrar

PARENTMED LIMITED

Unaudited Financial Statements

For the financial period from 24 April 2023 to 30 April 2024

Contents

PARENTMED LIMITED

STATEMENT OF FINANCIAL POSITION

As at 30 April 2024
PARENTMED LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 April 2024
Note 30.04.2024 23.04.2023
£ £
Current assets
Cash at bank and in hand 1,834 0
1,834 0
Creditors: amounts falling due within one year 3 ( 14,840) 0
Net current liabilities (13,006) 0
Total assets less current liabilities (13,006) 0
Net liabilities ( 13,006) 0
Capital and reserves
Called-up share capital 4 150 0
Profit and loss account ( 13,156 ) 0
Total shareholders' deficit ( 13,006) 0

For the financial period ending 30 April 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Parentmed Limited (registered number: 14823406) were approved and authorised for issue by the Board of Directors on 20 January 2025. They were signed on its behalf by:

Dr Munisha Balain
Director
PARENTMED LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 24 April 2023 to 30 April 2024
PARENTMED LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 24 April 2023 to 30 April 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

Parentmed Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2nd Floor Stratus House Emperor Way, Exeter Business Park, Exeter, EX1 3QS, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

Reporting period length is long due to this being the year of incorporation. It therefore runs from the 24 April 2023 to 30 April 2024.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

Period from
24.04.2023 to
30.04.2024
Period from
01.05.2022 to
23.04.2023
Number Number
Monthly average number of persons employed by the Company during the period, including directors 3 0

3. Creditors: amounts falling due within one year

30.04.2024 23.04.2023
£ £
Amounts owed to directors 12,500 0
Accruals 2,340 0
14,840 0

4. Called-up share capital

30.04.2024 23.04.2023
£ £
Allotted, called-up and fully-paid
150 Ordinary shares of £ 1.00 each (23.04.2023: nil shares) 150 0

5. Related party transactions

Transactions with the entity's directors

30.04.2024 23.04.2023
£ £
Amounts owed by/(to) the directors 12,500 0

The loans to the directors are repayable on demand and no interest is charged on the balances.